Cite
HARVARD Citation
Watson, G. et al. (2022). Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab. Journal for immunotherapy of cancer. 10 (6), p. . [Online].